About | Search | Report Feedback  

ASP Workshop on Diabetes Mellitus and Cardiovascular Disease in Older Adults

The Association of Specialty Professors (ASP) Workshop on Diabetes Mellitus and Cardiovascular Disease in Older Adults will be held April 4-5 , 2013, at the Ritz-Carlton Pentagon City in Arlington, VA. Unless otherwise noted, all files are in PDF format.

Please do not use material from these presentations without consulting the speaker or ASP.

Agenda

THURSDAY, APRIL 4, 2013

icgen.gifWelcome and Introductory Remarks
Kevin P. High, MD
Wake Forest University School of Medicine

Discussion Topic I: Clinical Epidemiology of Diabetes Mellitus and Concomitant Cardiovascular Disease in an Aging Population
Jeffrey B. Halter, MD, Moderator
University of Michigan Medical School

icgen.gifAge-related epidemiology of diabetes and pre-diabetes
Ed Gregg, PhD
Centers for Disease Control and Prevention

icgen.gifRacial and ethnic disparities
icgen.gifArticle One
icgen.gifArticle Two
Andrew Karter, PhD
Kaiser Permanente

icgen.gifInteraction of diabetes and age on CV events/outcomes
Jorge Kizer, MD
Albert Einstein College of Medicine

icgen.gifDiabetes related CV diseases and other diabetes related complications: Predicting outcomes and competing risks
icgen.gifArticle One
icgen.gifArticle Two
icgen.gifArticle Three
Elbert Huang, MD
University of Chicago Pritzker School of Medicine

icgen.gifHypoglycemia and CV risk
icgen.gifArticle One
icgen.gifArticle Two
Elizabeth Seaquist, MD
University of Minnesota Medical School

Moderator Wrap-up/ Group Discussion

Discussion Topic II: Common Metabolic Changes with AG and Their Impact on DM
Nir Barzilai, MD, Moderator
Albert Einstein College of Medicine

icgen.gifPathophysiology of age-related hyperglycemia: Insulin resistance and rejection
Nicolas Musi, MD
University of Texas Health Science Center at San Antonio

icgen.gifPathophysiology of age-related hyperglycemia: Impaired insulin

Jeffrey B. Halter, MD
University of Michigan Medical School

icgen.gifDiabetes, aging, lipid metabolism [Metabolic Syndrome]
Andy Goldberg, MD
University of Maryland Baltimore School of Medicine

icgen.gifDiabetes, aging and sarcopenia
Sree Nair, MD
Mayo Clinic College of Medicine

Moderator Wrap-up/ Group Discussion

Discussion Topic III: Vulnerabilities of the Heart and Blood Vessels to Aging and Diabetes
William Hazzard, MD, Moderator
University of Washington School of Medicine
VA Puget Sound Health Care System

icgen.gifAging and the heart
Ed Lakatta, PhD
National Institute on Aging

icgen.gifDiabetes and the heart
Jorge Plutzky, MD
Harvard Medical School, Brigham and Women's Hospital

icgen.gifAging and blood vessel regulation
Douglas Seals, PhD
University of Colorado

icgen.gifDiabetes and blood vessels
Michael Joyner, MD
Mayo Clinic College of Medicine

Moderator Wrap-up/ Group Discussion

icgen.gifDinner Presentation: “Insulin resistance and aging paradox: A cause or a protective response?"
Nir Barzilai, MD,
Albert Einstein College of Medicine

FRIDAY, APRIL 5, 2013

Discussion Topic IV: End-organ Sequelae That Lead to Disability
Robert Schwartz, MD, Moderator
University of Colorado School of Medicine

icgen.gifHeterogeneity of the older adult population with diabetes: Frailty, disability, and multiple comorbidities
Caroline Blaum, MD
New York University School of Medicine

icgen.gifInteractions of peripheral vascular disease with neuropathy
Lawrence Harkless, DPM
Western University of Health Sciences

icgen.gifImpact of other traditional diabetes complications on CV disease
Ian DeBoer, MD
University of Washington School of Medicine

icgen.gifImpact of non-traditional diabetes complications: Cognitive dysfunction
Suzanne Craft, PhD
Wake Forest University School of Medicine

Moderator Wrap-up/ Group Discussion

Discussion Topic V: Prevention and Treatments for CV Disease in Older Patients with Diabetes or Pre-Diabetes - Part 1
Sue Kirkman, MD, Moderator
University of North Carolina School of Medicine

icgen.gifChallenge of clinical intervention (RCT) in older persons with diabetes
Jeff Williamson, MD
Wake Forest University School of Medicine

icgen.gifDiabetes prevention: Lessons learned from DPP/DPPOS
Jill Crandall, MD
Albert Einstein College of Medicine

icgen.gifPossible influences of race/ethnicity on variable outcomes of clinical trials
Hermes Florez, MD, PhD
University of Miami Miller School of Medicine

Moderator Wrap-up/ Group Discussion

Discussion Topic V: Prevention and Treatments for CV Disease in Older Patients with Diabetes or Pre-Diabetes - Part 2
Andy Goldberg, MD, Moderator
University of Maryland Baltimore School of Medicine

icgen.gifChallenge of clinical intervention (RCT) in older persons with diabetes
Robert Eckel, MD
University of Colorado School of Medicine

icgen.gifVascular disease interventions
Masoor Kamalesh, MD
Indiana University School of Medicine

icgen.gifLifestyle interventions for older adults at risk for diabetes
icgen.gifArticle One
icgen.gifArticle Two
Dennis Villareal, MD,
University of New Mexico School of Medicine
New Mexico VA

Moderator Wrap-up/ Group Discussion